Literature DB >> 1660504

Time-course development of differentiated hepatocarcinoma and lung metastasis in transgenic mice.

N Dubois1, M Bennoun, I Allemand, T Molina, G Grimber, M Daudet-Monsac, R Abelanet, P Briand.   

Abstract

A precise targeting of the SV40 T early region expression in the liver of transgenic mice was obtained using 700 bp of the antithrombin III regulatory sequences to control oncogene expression. In the strain expressing the highest level of large T antigen (Tag), the incidence of hepatocarcinoma was 100%. The evolution was reproducible and characterized by a marked cytolysis occurring as early as 4 weeks, when no morphological and histological modifications were visible, a preneoplastic state marked by a progression from hyperplasia to proliferative nodules composed of highly differentiated cells exhibiting a high Tag expression, which elicited tumor formation in nude mice and could proliferate in vitro, and hepatocellular carcinoma associated, in 10% of the cases, with lung metastasis. These transgenic mice constituted a useful model for therapeutic assays and fundamental studies on carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660504     DOI: 10.1016/0168-8278(91)90819-w

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  23 in total

1.  Small interfering RNAs induce target-independent inhibition of tumor growth and vasculature remodeling in a mouse model of hepatocellular carcinoma.

Authors:  Mathieu Bergé; Philippe Bonnin; Eric Sulpice; José Vilar; David Allanic; Jean-Sébastien Silvestre; Bernard I Lévy; Gordon C Tucker; Gérard Tobelem; Tatyana Merkulova-Rainon
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

2.  Role of hypoxia-inducible transcription factor 1alpha for progression and chemosensitivity of murine hepatocellular carcinoma.

Authors:  Katjana Daskalow; Nadine Rohwer; Esther Raskopf; Evelyne Dupuy; Anja Kühl; Christoph Loddenkemper; Bertram Wiedenmann; Volker Schmitz; Thorsten Cramer
Journal:  J Mol Med (Berl)       Date:  2010-04-12       Impact factor: 4.599

Review 3.  Hepatic neoplasia: reflections and ruminations.

Authors:  K Aterman
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 4.  Mouse models for liver cancer.

Authors:  Latifa Bakiri; Erwin F Wagner
Journal:  Mol Oncol       Date:  2013-02-05       Impact factor: 6.603

Review 5.  Mouse models in liver cancer research: a review of current literature.

Authors:  Martijn W H Leenders; Maarten W Nijkamp; Inne H M Borel Rinkes
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

6.  Oval cell proliferation in early stages of hepatocarcinogenesis in simian virus 40 large T transgenic mice.

Authors:  M Bennoun; M Rissel; N Engelhardt; A Guillouzo; P Briand; A Weber-Benarous
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

Review 7.  Experimental models of hepatocellular carcinoma: developments and evolution.

Authors:  Long Wu; Zhao-You Tang; Yan Li
Journal:  J Cancer Res Clin Oncol       Date:  2009-04-28       Impact factor: 4.553

8.  Transgenic hepatocarcinogenesis in the rat.

Authors:  J R Hully; Y Su; J K Lohse; A E Griep; C A Sattler; M J Haas; Y Dragan; J Peterson; M Neveu; H C Pitot
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

Review 9.  Experimental mouse models for hepatocellular carcinoma research.

Authors:  Femke Heindryckx; Isabelle Colle; Hans Van Vlierberghe
Journal:  Int J Exp Pathol       Date:  2009-08       Impact factor: 1.925

Review 10.  Murine mentors: transgenic and knockout models of surgical disease.

Authors:  J M Arbeit; R Hirose
Journal:  Ann Surg       Date:  1999-01       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.